Begin main content

Drugs for Type 2 Diabetes: Second- and Third-Line Therapy Review Update

Published on: September 13, 2017
Result type: News

CADTH has completed its Therapeutic Review update of second-line therapies for patients with type 2 diabetes. The following reports are now available on the CADTH website:

  • final science report on second-line therapy (clinical and economic evaluations)
  • final recommendations report on second-line therapy

Supporting documents:

  • In Brief — a summary of the project including key messages
  • Project Protocol
  • Patient Input

Work is underway at CADTH on the third-line therapy review. Stay tuned for opportunities to provide feedback.

For more information, visit the project page at www.cadth.ca/newdrugst2dm.